Case Study

Objectives

• ATLAS and its preceding global AMR programmes have been running since 2004.
• AMR data for >900,000 clinical isolates are made available by the client for any registered user to analyse.
• Registration is free.
• Data can be sourced by the client or external users for AMR research.

Contribution

• Micron provides an open-access platform for users to analyse the global ATLAS database of in vitro activity of panel of antibiotics and antifungals.
• Data for >8 million records generated from analysis of >900,000 clinical isolates can be interrogated by pathogen, antimicrobial, demographic parameters, phenotype, or genotype.
• Micron receives raw data from the central laboratory, provides exhaustive QC using our closed testing systems and then release the data to a secure website that users can register without fees for open-access use.
• Custom reports show MIC Distribution, Susceptibility / Resistance rates, Geographical Heatmaps, and Demographic data.
• Every report can be downloaded and saved locally, from global overviews down to individual isolates.

Conclusion

The client’s decades-long commitment to AMR surveillance is reflected in the huge array of data going back to 2004 and being continuously added to. Micron’s proprietary MARS software engine allows thousands of freely-registered users to generate custom analyses and contribute to the fight against antimicrobial resistance. Visit atlas.surveillance.com to register and receive open access to anonymised AMR data for >900,000 clinical isolates.